MECHANISMS IN ENDOCRINOLOGY Vitamin D as a potential contributor in endocrine health and disease

dc.authorid0000-0002-8809-4931
dc.authorid0000-0001-5407-9576
dc.authorid0000-0002-4055-5233
dc.contributor.authorMuscogiuri, Giovanna
dc.contributor.authorMitri, Joanna
dc.contributor.authorMathieu, Chantal
dc.contributor.authorBadenhoop, Klaus
dc.contributor.authorTamer, Gonca
dc.contributor.authorOrio, Francesco
dc.contributor.authorMezza, Teresa
dc.date.accessioned2025-05-10T19:35:05Z
dc.date.issued2014
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractObjective: It has been suggested that vitamin D may play a role in the pathogenesis of several endocrine diseases, such as hyperparathyroidism, type 1 diabetes (T1DM), type 2 diabetes (T2DM), autoimmune thyroid diseases, Addison's disease and polycystic ovary syndrome (PCOS). In this review, we debate the role of vitamin D in the pathogenesis of endocrine diseases. Methods: Narrative overview of the literature synthesizing the current evidence retrieved from searches of computerized databases, hand searches and authoritative texts. Results: Evidence from basic science supports a role for vitamin D in many endocrine conditions. In humans, inverse relationships have been reported not only between blood 25-hydroxyvitamin D and parathyroid hormone concentrations but also with risk of T1DM, T2DM, and PCOS. There is less evidence for an association with Addison's disease or autoimmune thyroid disease. Vitamin D supplementation may have a role for prevention of T2DM, but the available evidence is not consistent. Conclusions: Although observational studies support a potential role of vitamin D in endocrine disease, high quality evidence from clinical trials does not exist to establish a place for vitamin D supplementation in optimizing endocrine health. Ongoing randomized controlled trials are expected to provide insights into the efficacy and safety of vitamin D in the management of endocrine disease.
dc.description.sponsorshipNational Institute of Diabetes and Digestive and Kidney Disease [R01DK76092, U01DK098245]; Office of the Director, National Institutes of Health; National Institutes of Health Office of Dietary Supplements from the American Diabetes Association [1-14-D2d-01]
dc.description.sponsorshipBy research grants R01DK76092 and U01DK098245 (to A G Pittas) from the National Institute of Diabetes and Digestive and Kidney Disease, the Office of the Director, National Institutes of Health, and the National Institutes of Health Office of Dietary Supplements and 1-14-D2d-01 (to A G Pittas) from the American Diabetes Association.
dc.identifier.doi10.1530/EJE-14-0158
dc.identifier.endpageR110
dc.identifier.issn0804-4643
dc.identifier.issn1479-683X
dc.identifier.issue3
dc.identifier.pmid24872497
dc.identifier.scopus2-s2.0-84907188253
dc.identifier.scopusqualityQ1
dc.identifier.startpageR101
dc.identifier.urihttps://doi.org/10.1530/EJE-14-0158
dc.identifier.urihttps://hdl.handle.net/20.500.14730/8749
dc.identifier.volume171
dc.identifier.wosWOS:000343670900003
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBioscientifica Ltd
dc.relation.ispartofEuropean Journal of Endocrinology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectPolycystic-Ovary-Syndrome
dc.subjectD-Receptor Gene
dc.subjectAutoimmune Thyroid-Diseases
dc.subjectDependent Diabetes-Mellitus
dc.subjectBeta-Cell Function
dc.subjectCod-Liver Oil
dc.subject1,25-Dihydroxyvitamin D-3
dc.subjectGraves-Disease
dc.subjectD Deficiency
dc.subjectNod Mice
dc.titleMECHANISMS IN ENDOCRINOLOGY Vitamin D as a potential contributor in endocrine health and disease
dc.typeReview

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
8749.pdf
Boyut:
155.61 KB
Biçim:
Adobe Portable Document Format